Cancer Screening Clause Samples

Cancer Screening. Effective upon City Council funding, as of June 7, 2017, all employees covered by this Agreement shall be permitted to use up to one (1) day of paid time, per calendar year, for cancer screening to run concurrent with leave permitted by the City’s Cancer Screening Policy. This leave will not be charged to any accrued leave. Leave may be used in half day increments. The screenings covered are: Breast, Colon, Skin, Thyroid, Oral Cavity, Lymph Nodes, Reproductive Organs and Lungs. Employees must have their health care provider complete the City’s Certification Form when administering the screening and employees must submit the completed form to their Department’s Personnel Officer for the benefit to be applied. Employees must comply with all notice and documentation requirements contained in the City of Boston Policy.

Cancer Screening. All bargaining unit members shall have access to 1 work day of leave for cancer screening concurrent with leave permitted by the City's Cancer Screening Policy. This leave will not be charged to any accrued leave. Leave may be used in half day increments. The screenings covered are: Breast, Colon, Skin, Thyroid, Oral Cavity, Lymph Nodes, Reproductive Organs and Lungs.

Cancer Screening. Each employee is entitled to take up to four (4) hours of paid leave for one (1) annual screening for breast cancer and prostate cancer.

Cancer Screening. Provider-based and Healthcare-based Barriers

Cancer Screening. All patients participating in this trial must undergo routine cancer screening. The history and diagnosis of potential or apparent malignant, and non-malignant diseases and neoplasms will be assessed through several diagnostic tests and procedures. Some diagnostic tests and procedures performed prior to study consent and documented in the patient’s medical history may be acceptable where noted. Routine cancer screening includes the following: 1. For patients ≥ 50 years old, colonoscopy within past 10 years 2. Chest X-ray or CT scan of the chest (if the patient has a previous history of tobacco use, a CT scan will be performed instead of the chest X-ray) within 3 months prior to study entry 3. Mammogram (females only)-within 1 year prior to study entry 4. Papanicolaou (Pap) testing - women within 1 year prior to study entry 5. Prostate specific antigen (PSA) – men within 3 months prior to study entry The cancer screening tests performed at baseline for this protocol are consistent with the American Cancer Society “Guidelines for the Early Detection of Cancer” dated: 3/28/07 (see Appendix 6).

Cancer Screening. The Hospital shall provide each employee with four (4) hours of paid leave for cancer screening on an annual basis. The four hours can be used for both appointments and preparation time scheduled during the employee’s work time. The employee will provide his/her supervisor with documentation of the screening appointment, and provide a minimum of five (5) days notice to the Hospital of the appointment unless the screening is of an emergent nature.

Cancer Screening. All patients participating in this trial must undergo routine cancer screening. The history and diagnosis of potential or apparent malignant and non-malignant diseases and neoplasms will be assessed through several diagnostic tests and procedures. Some diagnostic tests and procedures performed prior to study consent and documented in the patient’s medical history may be acceptable where noted. Routine cancer screening includes the following: 1. For patients ≥ 50 years old, colonoscopy within past 10 years. Note: FOBT is not required since colonoscopy will be performed to screen for colon cancer. 2. Chest X-ray or CT scan of the chest (if the patient has a previous history of tobacco use, a CT scan will be performed instead of the chest X-ray) within 3 months prior to study entry 3. Mammogram (females only)-within 1 year prior to study entry 4. Papanicolaou (Pap) testing - women within 1 year prior to study entry 5. Prostate specific antigen (PSA) – men within 3 months prior to study entry The cancer screening tests performed at baseline for this protocol are consistent with the American Cancer Society “Guidelines for the Early Detection of Cancer” dated: 3/28/07 (see Appendix 7).

Cancer Screening. The parties to this agreement recognise the value of early detection in reducing special dangers from cervical; breast; testicular; prostrate and other cancers and are committed to encouraging employees in the industry to undergo screening at the recommended frequency. It is recommended that on- site screening facilities be provided where justified by the number of employees. Where this is not possible, however, individuals will need to make their own arrangements for cancer screening, and provided mutually acceptable arrangements are made, taking account of company shift patterns, and where applicable, and evidence of attendance given, employees shall receive reasonable time-off with pay for this purpose.

Cancer Screening. The Employer agrees to incur all costs for firefighter cancer screening tests. These cancer screens will be firefighter specific tests and offered during the second year of this bargaining agreement. If an employee chooses not to participate or is unable to attend it will not be offered at any other time during this agreement. Both parties will mutually agree to the company performing the scans such as Lifescan, United Diagnostic Services, or NDS Wellness. The testing dates shall be coordinated by the Union. All results will remain confidential and go directly to the employee.